The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study
Abstract Background The projection studies are imperative to satisfy demands for health care systems and proper response to the public health problems such as inflammatory bowel disease (IBD). Methods To accomplish this, we established an illness-death model based on available data to project the future prevalence of IBD in Asia, Iran in particular, separately from 2017 to 2035. We applied two deterministic and stochastic approaches. Results In 2035, as compared to 2020, we expected a 2.5-fold rise in prevalence for Iran with 69 thousand cases, a 2.3-fold increment for North Africa and the Middle East with 220 thousand cases, quadrupling of the prevalence for India with 2.2 million cases, a 1.5-fold increase for East Asia region with 4.5 million cases, and a 1.6-fold elevation in prevalence for high‐income Asia‐Pacific and Southeast Asia regions with 183 and 199 thousand cases respectively. Conclusions Our results showed an emerging epidemic for the prevalence of IBD in Asia regions and/or countries. Hence, we suggest the need for immediate action to control this increasing trend in Asia and Iran. However, we were virtually unable to use information about age groups, gender, and other factors influencing the evolution of IBD in our model due to lack of access to reliable data..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
BMC Gastroenterology - 21(2021), 1, Seite 8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Meysam Olfatifar [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Asia regions |
|---|
| doi: |
10.1186/s12876-021-01745-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ059130504 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ059130504 | ||
| 003 | DE-627 | ||
| 005 | 20230308231857.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12876-021-01745-1 |2 doi | |
| 035 | |a (DE-627)DOAJ059130504 | ||
| 035 | |a (DE-599)DOAJ7bbcd2d0f64a45aebe53c99a3affd101 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC799-869 | |
| 100 | 0 | |a Meysam Olfatifar |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background The projection studies are imperative to satisfy demands for health care systems and proper response to the public health problems such as inflammatory bowel disease (IBD). Methods To accomplish this, we established an illness-death model based on available data to project the future prevalence of IBD in Asia, Iran in particular, separately from 2017 to 2035. We applied two deterministic and stochastic approaches. Results In 2035, as compared to 2020, we expected a 2.5-fold rise in prevalence for Iran with 69 thousand cases, a 2.3-fold increment for North Africa and the Middle East with 220 thousand cases, quadrupling of the prevalence for India with 2.2 million cases, a 1.5-fold increase for East Asia region with 4.5 million cases, and a 1.6-fold elevation in prevalence for high‐income Asia‐Pacific and Southeast Asia regions with 183 and 199 thousand cases respectively. Conclusions Our results showed an emerging epidemic for the prevalence of IBD in Asia regions and/or countries. Hence, we suggest the need for immediate action to control this increasing trend in Asia and Iran. However, we were virtually unable to use information about age groups, gender, and other factors influencing the evolution of IBD in our model due to lack of access to reliable data. | ||
| 650 | 4 | |a Asia regions | |
| 650 | 4 | |a Iran | |
| 650 | 4 | |a Inflammatory Bowel Disease | |
| 650 | 4 | |a Projection | |
| 650 | 4 | |a Emergency action | |
| 653 | 0 | |a Diseases of the digestive system. Gastroenterology | |
| 700 | 0 | |a Mohammad Reza Zali |e verfasserin |4 aut | |
| 700 | 0 | |a Mohamad Amin Pourhoseingholi |e verfasserin |4 aut | |
| 700 | 0 | |a Hedieh Balaii |e verfasserin |4 aut | |
| 700 | 0 | |a Shaghayegh Baradaran Ghavami |e verfasserin |4 aut | |
| 700 | 0 | |a Maria Ivanchuk |e verfasserin |4 aut | |
| 700 | 0 | |a Pavlo Ivanchuk |e verfasserin |4 aut | |
| 700 | 0 | |a Saeed hashemi Nazari |e verfasserin |4 aut | |
| 700 | 0 | |a Shabnam shahrokh |e verfasserin |4 aut | |
| 700 | 0 | |a Siamak Sabour |e verfasserin |4 aut | |
| 700 | 0 | |a Soheila Khodakarim |e verfasserin |4 aut | |
| 700 | 0 | |a Hamid Asadzadeh Aghdaei |e verfasserin |4 aut | |
| 700 | 0 | |a Pejman Rohani |e verfasserin |4 aut | |
| 700 | 0 | |a Gholamhossein Mehralian |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t BMC Gastroenterology |d BMC, 2003 |g 21(2021), 1, Seite 8 |w (DE-627)DOAJ000072664 |x 1471230X |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2021 |g number:1 |g pages:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12876-021-01745-1 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/7bbcd2d0f64a45aebe53c99a3affd101 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12876-021-01745-1 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1471-230X |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2021 |e 1 |h 8 | ||